Fitzgerald Industries International, Inc. CA 27-29 protein 30C-CP9064

Description
Partially pure, low cross grade, Human CA 27-29 protein Background: CA 27-29 (Cancer Antigen 27-29) is a breast tumor marker. Diagnostic tests measuring the MUC1- glycoprotein are FDA/EU approved including CA 15-3, CA 27-29 and Br assays. Reoccurrence detection of breast cancer by MUC-1 assay can preceed confirmation by radiological detection methods by 1-9 months.
Description
Partially pure, low cross grade, Human CA 27-29 protein Background: CA 27-29 (Cancer Antigen 27-29) is a breast tumor marker. Diagnostic tests measuring the MUC1- glycoprotein are FDA/EU approved including CA 15-3, CA 27-29 and Br assays. Reoccurrence detection of breast cancer by MUC-1 assay can preceed confirmation by radiological detection methods by 1-9 months.

Suppliers

Company
Product
Description
Supplier Links
Fitzgerald Industries International, Inc.
Acton, MA, USA
CA 27-29 protein
30C-CP9064
CA 27-29 protein 30C-CP9064
Partially pure, low cross grade, Human CA 27-29 protein Background: CA 27-29 (Cancer Antigen 27-29) is a breast tumor marker. Diagnostic tests measuring the MUC1- glycoprotein are FDA/EU approved including CA 15-3, CA 27-29 and Br assays. Reoccurrence detection of breast cancer by MUC-1 assay can preceed confirmation by radiological detection methods by 1-9 months.

Partially pure, low cross grade, Human CA 27-29 protein
Background:
CA 27-29 (Cancer Antigen 27-29) is a breast tumor marker. Diagnostic tests measuring the MUC1- glycoprotein are FDA/EU approved including CA 15-3, CA 27-29 and Br assays. Reoccurrence detection of breast cancer by MUC-1 assay can preceed confirmation by radiological detection methods by 1-9 months.

Supplier's Site

Technical Specifications

  Fitzgerald Industries International, Inc.
Product Category Biological Materials
Product Number 30C-CP9064
Product Name CA 27-29 protein
Unlock Full Specs
to access all available technical data

Similar Products